depends what they announce the ratio as. say it's 30:1, you get 1,000 shares of the new class stock, 3,000 if it's 10:1
it's a true long play; this is the first widely publicly known medical marijuana company out there. we all know the benefits of the substance, so regardless the legality (prop 19) we still have shares of a company that's got more than one drug in development that the FDA has already said it would review for usage on PTSD patients. one way or another this one has more upward potential and i'm hanging in there until i get it. 'tis better to have not sold, than to have sold and lost
